Background: Biventricular (BiV) pacing is an established therapy for heart failure in ischaemic and dilated cardiomyopathy. Its effects in end-stage hypertrophic cardiomyopathy (HCM) are unknown.

Aims: To assess the potential benefits of BiV pacing in patients with symptomatic end-stage HCM.

Methods: Twenty patients with non-obstructive HCM (12 male, mean age 57+/-13 years), left bundle branch block and symptoms of heart failure refractory to medical therapy underwent implantation of a BiV device. NYHA class, echocardiographic parameters and exercise capacity were assessed before and after implantation.

Results: At a mean follow-up of 13+/-6 months, an improvement of at least one NYHA class was reported in 8 (40%) patients. A clinical response was associated with an increase in ejection fraction (from 41+/-14% to 50+/-12%, p=0.009), and reductions in left ventricular end-diastolic diameter (from 57+/-6 mm to 52+/-7 mm, p=0.031) and left atrial diameter (from 65+/-8 mm to 57+/-6 mm, p=0.005). Percentage predicted peak oxygen consumption was unchanged in responders but significantly declined in non-responders (p=0.029).

Conclusions: BiV pacing improved heart failure symptoms in a significant proportion of patients with end-stage HCM. Symptomatic improvement was associated with reverse remodelling of the left atrium and ventricle.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejheart.2008.03.006DOI Listing

Publication Analysis

Top Keywords

biv pacing
12
heart failure
12
patients end-stage
8
end-stage hypertrophic
8
hypertrophic cardiomyopathy
8
nyha class
8
patients
5
biventricular pacing
4
pacing symptoms
4
symptoms cardiac
4

Similar Publications

Impact of Multidirectional Pacing on Activation and Repolarization Parameters to Localize Ischemic Ventricular Tachycardia Circuits.

JACC Clin Electrophysiol

November 2024

Centre for Translational Electrophysiology, Institute of Cardiovascular Science, University College London, London, United Kingdom; Department of Electrophysiology, Barts Heart Centre, St. Bartholomew's Hospital, London, United Kingdom. Electronic address:

Background: In ventricular tachycardia (VT), optimal substrate mapping strategies identifying arrhythmogenic sites are not established.

Objectives: This study sought to evaluate multidirectional pacing on the distribution of specific conduction and repolarization metrics to localize re-entrant VT sites in a porcine infarct model.

Methods: Substrate maps were created in 13 pigs with chronic myocardial infarction using the Advisor HD Grid (Abbott) during right ventricular (RV), left ventricular, biventricular pacing (BIV), and sinus rhythm (SR).

View Article and Find Full Text PDF
Article Synopsis
  • A 74-year-old male with Kartagener's syndrome and permanent atrial fibrillation underwent successful cardiac resynchronization therapy (CRT) and atrioventricular node (AVN) ablation using remote magnetic navigation (RMN) through peripheral access.
  • The patient had severe heart failure, a low ejection fraction of 30%, and significant complications from a left bundle branch block, leading to unsuccessful bi-ventricular pacing prior to the procedure.
  • Post-ablation, the patient's bi-ventricular pacing efficiency improved to 100%, and there were notable improvements in both cardiac function and overall symptoms, highlighting the effectiveness of RMN-guided techniques in treating complex cardiac cases.
View Article and Find Full Text PDF
Article Synopsis
  • The QLV ratio is an important measurement during cardiac resynchronization therapy (CRT) that helps predict how effective the treatment will be.
  • A new technique called left bundle branch area pacing-optimized CRT (LOT-CRT) shows promise in enhancing outcomes for patients even if the ideal lead placement isn't possible.
  • In a study of 72 patients, those who received LOT-CRT had more significant improvements in heart function and symptoms compared to traditional biventricular CRT (Biv-CRT), especially for those with lower QLV ratios.
View Article and Find Full Text PDF
Article Synopsis
  • Cardiac resynchronization therapy (CRT) using biventricular (BIV) pacing is aimed at heart failure patients but some don't respond; MultiPoint Pacing (MPP) might offer better results for these non-responders.
  • In a study with 3724 patients treated with BIV, 1639 were identified as non-responders and some were randomized to MPP or continued BIV pacing.
  • Results showed MPP led to better outcomes with a 33% success rate in reducing heart failure events compared to 23.5% in BIV, and MPP also resulted in fewer hospitalizations for heart failure.
View Article and Find Full Text PDF
Article Synopsis
  • Biventricular pacing (BIV) is the standard treatment for cardiac resynchronization therapy (CRT), but 30% of patients do not respond; conduction system pacing (CSP) is an alternative worth exploring.
  • A study involving 96 patients compared outcomes based on intraoperative measurements of interventricular conduction delay (IVCD) to determine whether BIV or CSP would be more effective.
  • Results showed that patients in the group evaluated for IVCD had significantly higher response rates to CRT, suggesting that this assessment can inform better treatment choices.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!